For instance, liver injury associated with anti-PD-1 checkpoint treatment appears to lack certain features of autoimmune hepatitis, such as anti-nuclear antibodies, hypergammaglobulinemia, and a predominance in females [74]. The gene discussed is PDCD1; the disease is autoimmune hepatitis.